Biotech builder ElevateBio reveals its first portfolio company: AlloVir - FierceBiotech
Biotech builder ElevateBio reveals its first portfolio company: AlloVir FierceBiotech
A week after launching with $150 million, ElevateBio is unveiling its first portfolio company: AlloVir, a biotech working on off-the-shelf cell therapies against ...
Comments
Post a Comment